Search

Your search keyword '"TARANTINO L"' showing total 44 results
Start Over Author "TARANTINO L" Publisher elsevier bv
44 results on '"TARANTINO L"'

13. P.1.159: REPEATED LOCO-REGIONAL TREATMENTS: HIGH SURVIVAL RATES IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA HIGHLY COMPLIANT TO SCHEDULED FOLLOW-UP

Author

Tarantino, L., primary, Sabbatino, F., additional, Sordelli, I., additional, Ripa, C., additional, Celiento, M., additional, Cuccorese, G., additional, Tambaro, O., additional, Villanacci, A., additional, Nocera, V., additional, Perrotta, M., additional, Iside, G., additional, and Sperlongano, P., additional

Published
2011
Full Text
View/download PDF

19. 785 SORAFENIB PLUS OCTREOTIDE IN ADVANCED HEPATOCELLULAR CARCINOMA: UPDATED RESULTS OF A MULTICENTER STUDY

Author

Del Prete, S., primary, Addeo, R., additional, Caraglia, M., additional, Maiorino, L., additional, Montesarchio, V., additional, Cennamo, G., additional, Guarrasi, R., additional, Faiola, V., additional, Leo, L., additional, Febbraro, A., additional, Vincenzi, B., additional, Savastano, C., additional, Tarantino, L., additional, Sabia, A., additional, Capasso, E., additional, Palmieri, G., additional, Giorgio, A., additional, Bianco, M., additional, and Montella, L., additional

Published
2009
Full Text
View/download PDF

24. Sorafenib plus long-acting octreotide in advanced hepatocellular carcinoma. Preliminary results of a multicenter ongoing study

Author

Del Prete, S., primary, Addeo, R., additional, Maiorino, L., additional, Cennamo, G., additional, Montesarchio, V., additional, Leo, L., additional, Faiola, V., additional, Guarrasi, R., additional, Tarantino, L., additional, Vascone, A., additional, D’Agostino, A., additional, Palmieri, G., additional, Bianco, M., additional, Caraglia, M., additional, Pizza, C., additional, Mamone, R., additional, and Montella, L., additional

Published
2008
Full Text
View/download PDF

28. M.P.1.14 Asymptomatic mitochondrial myopathy with mtDNA multiple deletions revealed by propofol-induced multiple organ failure with rhabdomyolysis

Author

Carroccia, R., primary, Rinaldi, R., additional, Cenacchi, G., additional, Badiali De Giorgi, L., additional, Tarantino, L., additional, Valentino, M., additional, Baldin, E., additional, Pizza, F., additional, La Morgia, C., additional, Coccolo, F., additional, Zavatta, M., additional, Santoro, A., additional, and Carelli, V., additional

Published
2007
Full Text
View/download PDF

43. Ultrasound-guided percutaneous ethanol injection under general anesthesia for the treatment of hepatocellular carcinoma on cirrhosis: long-term results in 268 patients

Author

Luciano Tarantino, A. Alaia, V Aloisio, Antonio Giorgio, Gennaro Lettieri, Giorgio de Stefano, Luca Del Viscovo, A. Perrotta, Giorgio, A, Tarantino, L, DE STEFANO, G, Perrotta, A, Aloisio, V, DEL VISCOVO, Luca, Alaia, A, and Lettieri, G.

Subjects
Adult, Liver Cirrhosis, Male, Carcinoma, Hepatocellular, Cirrhosis, Acoustics and Ultrasonics, General Chemical Engineering, medicine.medical_treatment, Bioengineering, Anesthesia, General, Statistics, Nonparametric, Injections, Postoperative Complications, medicine, Humans, Radiology, Nuclear Medicine and imaging, Liver neoplasm, Hemoperitoneum, Survival rate, Ultrasonography, Interventional, Aged, Aged, 80 and over, Ethanol, business.industry, Liver Neoplasms, Nodule (medicine), Middle Aged, medicine.disease, Survival Rate, Treatment Outcome, Hepatocellular carcinoma, Anesthesia, Female, medicine.symptom, Percutaneous ethanol injection, Tomography, X-Ray Computed, Complication, business
Abstract

Objective: Percutaneous ethanol injection (PEI) under general anesthesia (One-shot PEI) is a therapy for large and multiple hepatocellular carcinoma (HCC) by the injection of a large amount of ethanol into the tumor. We report our results with 5-year survival rates in patients with HCC on cirrhosis treated with One-shot PEI. Patients and methods: From October 1992 to March 1998, 268 cirrhotic patients (age 42–82 years; 191 males; 95 Child-Pugh's A class, 150 B and 23 C class of cirrhosis) with 515 HCC nodules underwent One-shot PEI. Diameter of HCC nodules ranged from 0.6 to 14 cm (mean 5.02±2.2 cm; median: 4 cm). One hundred and thirty-eight patients had a single nodule (range 3.2–14 cm; mean 5.6±2.1 cm), 130 had multiple nodules, up to six nodules (mean 2.9 nodules) (range 0.6–11 cm; mean 4.8±2.1 cm) Results: CT showed complete necrosis in 357/506 nodules (70%). Five patients (1.8%) with nine nodules died as a result of the procedure (variceal bleeding in three cases, liver failure in one and hemoperitoneum in one). The overall survival rates were 93, 83, 74, 65 and 59% at 1, 2, 3, 4 and 5 years, respectively. Survival rates were 90, 84, 82 and 82% at 12, 24, 36 and 48 months, respectively, in patients with a single nodule ≤5 cm, and 97, 71, 59, 59 and 59% at 12, 24, 36, 48 and 60 months, respectively, in patients with single nodule >5 cm. Patients with multiple nodules had survival rates of 97, 89, 75, 60 and 60% at 12, 24, 36, 48 and 60 months, respectively. Conclusion: PEI of large and multiple HCC showed survivals similar to conventional PEI for patients with smaller tumors.

Published
2000

44. Reverse flow in intrahepatic portal vessels and liver function impairment in cirrhosis

Author

V Aloisio, A. Giorgio, N. Mariniello, G. de Stefano, L Del Viscovo, A. Perrotta, MC Forestieri, G Borsellino, Luciano Tarantino, Tarantino, L, Giorgio, A, DE STEFANO, G, Mariniello, N, Perrotta, A, Aloisio, V. V., Forestieri, Mc, DEL VISCOVO, Luca, and Borsellino, G.

Subjects
medicine.medical_specialty, Cirrhosis, Acoustics and Ultrasonics, Vascular disease, business.industry, General Chemical Engineering, Left gastric vein, Hemodynamics, Bioengineering, medicine.disease, Gastroenterology, Surgery, Splenic vein, Internal medicine, medicine, Portal hypertension, Radiology, Nuclear Medicine and imaging, Liver function, Superior mesenteric vein, business
Abstract

Objectives: Our aim was to describe the hemodynamic patterns and assess the prevalence of reversal of flow (RF) in intrahepatic portal vessels (IPV) in patients with chronic active hepatitis (CAH) and patients with cirrhosis. Patients : 100 consecutive patients with CAH, and 178 consecutive cirrhotic patients (48 Child A, 114 Child B and 38 Child C class) underwent Echo-Color-Doppler for evaluation of flow direction in segmental IPV, right and left portal vein (RPV, LPV), in main portal vein (MPV), splenic vein (SV), superior mesenteric vein (SMV) and porto-systemic shunts (paraumbilical, spleno-renal, left gastric vein). The patients were followed-up clinically for 3-15 months. Results: Patients with CAH showed RF in SV in 1/100 and hepatopetal flow in MPV, SMV, SV, IPV in 99/100 patients. Eleven of 178 (6.2%) cirrhotic patients showed RF only in the SV, 3/178 (1.7%) showed alternating ('back and forth') flow only in IPV, RPV and LPV with continuous hepatopetal flow in PV and 10/178 (5.6%) showed completely RF in IPV. Four of ten patients of this last group showed hepatopetal flow in MPV. The other six patients showed RF in MPV associated with hepatofugal flow through a large left gastric vein in three cases and through the SV in three cases. The other cirrhotic patients (154/178=86.5%) showed hepatopetal flow in IPV, MPV, SMV and SV. In no case RF in SMV was observed. Prevalence of RF in IPV was significantly higher in Child C patients (8/31=25.8%) than Child B patients (5/104=4.7%) and than in Child A patients (0%) (p0.01). Prevalence of Child C class was significantly higher in patients with RF in IPV (8/13=61.5%) than in patients with RF only in extraepatic portal vessels (2/11=18.2%) and patients without RF (21/154=13.6%) (p0.001). No patient with RF in IPV was in Child A class. Incidence of death was significantly higher in patients with RF in IPV than in patients without RF and patients with RF only in SV. Conclusions: RF in IPV is not a rare event (9% in our series) that mainly occurs in cirrhosis with advanced liver function impairment. Copyright 1997 Elsevier Science Ireland Ltd.

Published
1997

Catalog

Books, media, physical & digital resources
See catalog results